Rapport Therapeutics, Inc. (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

48.77

-2.06 (-4.05%)

At close: Aug 28, 2026, 4:00 PM EDT

48.81

+0.04 (0.08%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Rapport Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	63.61	52.65	56.81	70.17	31.16
Short-Term Investments	372.47	437.89	248.48	77.31	-
Cash & Short-Term Investments	436.08	490.54	305.28	147.48	31.16
Cash Growth	67.43%	60.69%	107.00%	373.31%	-
Prepaid Expenses	10.28	7.82	4.42	1.5	0.11
Restricted Cash	0.11	0.11	0.11	0.09	-
Other Current Assets	0.1	0.1	-	1.81	-
Total Current Assets	446.86	498.56	309.8	150.87	31.27
Property, Plant & Equipment	11.07	12.89	4.97	4	0.34
Long-Term Deferred Charges	-	0.04	-	0.3	-
Other Long-Term Assets	1.06	0.95	0.16	0.25	-
Total Assets	458.98	512.43	314.93	155.42	31.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	2.8	4.19	1.95	2.5	1.45
Accrued Expenses	23.16	12.1	6.08	5.63	0.21
Current Portion of Leases	2.47	2.76	0.74	0.67	-
Total Current Liabilities	28.42	19.05	8.77	8.8	1.66
Long-Term Debt	-	-	-	4.2	10.44
Long-Term Leases	7.63	8.73	0.74	1.48	-
Total Liabilities	36.06	27.78	9.51	14.48	12.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.05	0.05	0.04	0	0.03
Additional Paid-In Capital	735.85	719.29	429.66	19.8	0.56
Retained Earnings	-311.7	-235.23	-123.75	-45.44	-10.65
Comprehensive Income & Other	-1.27	0.55	-0.52	0	-
Total Common Equity	422.93	484.65	305.43	-25.63	-10.06
Shareholders' Equity	422.93	484.65	305.43	140.94	19.51
Total Liabilities & Equity	458.98	512.43	314.93	155.42	31.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	10.11	11.48	1.48	6.35	10.44
Net Cash (Debt)	425.97	479.06	303.8	141.13	20.72
Net Cash Growth	71.36%	57.69%	115.26%	581.01%	-
Net Cash Per Share	9.48	12.30	14.65	93.73	26.66
Filing Date Shares Outstanding	47.98	47.79	36.5	4.17	0.78
Total Common Shares Outstanding	47.96	47.77	36.58	4.17	0.78
Working Capital	418.43	479.51	301.04	142.07	29.61
Book Value Per Share	8.82	10.15	8.35	-6.15	-12.95
Tangible Book Value	422.93	484.65	305.43	-25.63	-10.06
Tangible Book Value Per Share	8.82	10.15	8.35	-6.15	-12.95
Machinery	4.18	4.55	3.78	1.76	0.3
Construction In Progress	-	0.12	0.43	0.03	0.06
Leasehold Improvements	0.3	0.3	0.28	0.26	-

SEC Filings: 10-K · 10-Q